Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction

Authors
Cohen, M Antman, EM Gurfinkel, E Turpie, AGG Furst, J Bigonzi, F Radley, D
Citation
M. Cohen et al., Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction, AM J CARD, 86(5), 2000, pp. 553
Citations number
20
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF CARDIOLOGY
ISSN journal
00029149 → ACNP
Volume
86
Issue
5
Year of publication
2000
Database
ISI
SICI code
0002-9149(20000901)86:5<553:IOELMW>2.0.ZU;2-5
Abstract
A subgroup meta-analysis from the Efficacy and Safety of Subcutaneous Enoxa parin in in Non-Q-Wave Coronary Events (ESSENCE and the Thrombolysis in Myo cardial Infarction (TIMI) 11B studies has shown that enoxaparin is superior to unfractionated heparin in reducing the composite end points of death, m yocardial infarction, and emergency revascularization in patients with Q-wa ve myocardial infarction. The beneficial treatment effect was significant a t 43 days.